Amyloidosis News Today Columnist jobs in United States
cer-icon
Apply on Employer Site
company-logo

Bionews, Inc. · 2 months ago

Amyloidosis News Today Columnist

Bionews, Inc. is a digital news company focused on creating communities for patients with rare and chronic diseases. They are seeking a columnist from the transthyretin amyloid cardiomyopathy community to write personal essays that inform and inspire others about living with these conditions.

Clinical TrialsDigital MediaHealth CareLife SciencePublishing

Responsibilities

Fulfill 1x weekly deadlines as agreed upon on hire
Communicate efficiently with your managers and editors
Submit 400-800 word drafts that adhere to Bionews policies and procedures
Aside from exceptions, drafts should not take more than 45 minutes to edit
Fulfill revisions as requested by editors in a timely manner
Complete training assigned by Bionews HR

Qualification

Advanced creative writingInternet technology learningTime managementWordPress experienceSlack experienceNative English proficiency

Required

You MUST be a member of the ATTR-CM community in order to apply for this position
Prior experience with writing for an audience
At least three months' direct experience with having or caring for someone with ATTR-CM
Caregivers must be direct relatives, guardians, or spouses
Fundamentals of how ATTR-CM works
A swift and independent learner of Internet technology
A creative mind capable of regularly generating unique content that appeals to target audiences
Time management
Advanced creative writing
Internet access and use
Native or fluent English writing and reading abilities

Preferred

Experience in being professionally edited for publication
Experienced in generating a blog or column
Participation in support groups, internet forums, or community groups relevant to ATTR-CM
Experience in using WordPress for content creation
Experience with the Slack communication app

Company

Bionews, Inc.

twittertwittertwitter
company-logo
Bionews is a digital health solutions company dedicated to empowering more than 50 rare disease communities with trusted information, news, and connections.

Funding

Current Stage
Growth Stage

Leadership Team

leader-logo
Chris Comish
Founder / CEO
linkedin
leader-logo
Jeff LaPointe
Executive Vice President of Technology
linkedin
Company data provided by crunchbase